Results 61 to 70 of about 1,741 (203)

Meeting Report of the 13th Congress of the International Society of Vascularized Composite Allotransplantation

open access: yes, 2018
The International Society of Vascularized Composite Allotransplantation held its 13th congress "Defining Success" in October 2017 in Salzburg, Austria. A total of 122 delegates from 22 countries representing 5 continents attended the conference.
Lawrence Scott Levin   +36 more
core   +2 more sources

supplementary_material - A Lifesaving View of Vascularized Composite Allotransplantation: Patient Experience of Social Death Before and After Face, Hand, and Larynx Transplant [PDF]

open access: yes, 2017
supplementary_material for A Lifesaving View of Vascularized Composite Allotransplantation: Patient Experience of Social Death Before and After Face, Hand, and Larynx Transplant by Katrina A Bramstedt in Journal of Patient ...
Katrina A Bramstedt PhD, MA   +3 more
core   +1 more source

Transcription Factor Blimp-1: A Central Regulator of Oxidative Stress and Metabolic Reprogramming in Chronic Inflammatory Diseases

open access: yesAntioxidants
B-lymphocyte-induced maturation protein 1 (Blimp-1) is a transcription factor that, among other functions, modulates metabolism and helps to regulate antioxidant pathways, which is important in the context of chronic inflammatory diseases like diabetes ...
Aline Yen Ling Wang   +4 more
doaj   +1 more source

A Mixed Thermosensitive Hydrogel System for Sustained Delivery of Tacrolimus for Immunosuppressive Therapy

open access: yesPharmaceutics, 2019
Tacrolimus is an immunosuppressive agent for acute rejection after allotransplantation. However, the low aqueous solubility of tacrolimus poses difficulties in formulating an injection dosage.
Hsiu-Chao Lin   +8 more
doaj   +1 more source

Development of a Swine Whole Eye Transplant Ex Vivo Perfusion Protocol

open access: yesArtificial Organs, Volume 50, Issue 5, Page 764-772, May 2026.
This study establishes the first subnormothermic machine perfusion protocol for whole eye transplants in a swine model, enabling up to 18 h of preservation with stable metabolic function, limited edema, and recovery of mydriasis. ABSTRACT Background The first human Whole Eye Transplant (WET) has sparked new hope for patients who have lost vision due to
Haïzam Oubari   +8 more
wiley   +1 more source

Kidney Dysfunction After Vascularized Composite Allotransplantation

open access: yesTransplantation Direct, 2018
Background Kidney dysfunction is a major complication after nonrenal solid organ transplants. Transplantation of vascularized composite allografts (VCA) has yielded successful midterm outcomes despite high rates of acute rejection and greater requirements of immunosuppression.
Krezdorn N   +10 more
openaire   +3 more sources

Optimized Decellularization of a Porcine Fasciocutaneaous Flap

open access: yesBioengineering
Reconstructive techniques to repair severe tissue defects include the use of autologous fasciocutaneous flaps, which may be limited due to donor site availability or lead to complications such as donor site morbidity.
Elise Lupon   +9 more
doaj   +1 more source

Mesenchymal Stem Cells as Immunomodulators in a Vascularized Composite Allotransplantation

open access: yesClinical and Developmental Immunology, 2012
Vascularized composite allotransplantations (VCAs) are not routinely performed for tissue reconstruction because of the potentially harmful adverse effects associated with lifelong administration of immunosuppressive agents. Researchers have been eagerly
Yur-Ren Kuo   +5 more
doaj   +1 more source

Thermosensitive Polyester Hydrogel for Application of Immunosuppressive Drug Delivery System in Skin Allograft

open access: yesGels, 2021
Tacrolimus (FK506) is a common immunosuppressive drug that is capable of suppressing acute rejection reactions, and is used to treat patients after allotransplantation.
I-En Wu   +5 more
doaj   +1 more source

Xenoperfusion—The Transformative Role of Machine Perfusion in Xenotransplantation

open access: yesXenotransplantation, Volume 33, Issue 3, May/June 2026.
ABSTRACT Recent advances in xenotransplantation have gained substantial public and clinical attention as genetically modified porcine organs are now being transplanted into living human recipients. While only case reports have been published to date, the first clinical trials for kidney xenotransplantation are now ongoing.
Florian Huwyler   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy